Edward Maytin, MD, is Section Head of Molecular Dermatology in the Department of Dermatology, as well as a Staff Member in the Department of Biomedical Engineering at Cleveland Clinic’s Main Campus. He is also an Assistant Professor of Chemistry and Biomedical Engineering at Cleveland State University and Assistant Professor in the Department of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Dr. Maytin earned his medical degree from the University of Rochester School of Medicine and Dentistry in Rochester, NY. He completed an internship at Roger Williams Medical Center in Providence, RI. He completed a residency in dermatology and fellowship in endocrinology through Harvard Medical School and Massachusetts General Hospital in Boston, Mass.

He is a Diplomate of the National Board of Medical Examiners, as well as the American Board of Dermatology.

Dr. Maytin is a member of several medical societies, including the American Medical Association, the American Academy of Dermatology, the Society of Investigative Dermatology and the American Cancer Society.

He has published a number of articles, reviews, chapters and editorials on various topics in dermatology.

• Recipient of ongoing grant funding from National Institutes of Health (NIH)
• Investigator-initiated research on photodynamic therapy
• Head of Section on Molecular Dermatology
• Director, Laboratory of Molecular Dermatology

Residency - Massachusetts General Hospital

Dermatology
Boston, MA USA
1990

Fellowship - Massachusetts General Hospital

Dermatology (Photomedicine)
Boston, MA USA
1987

Internship - Roger Williams Medical Center

Internal Medicine
Providence, RI USA
1986

Medical School - University of Rochester School of Medicine and Dentistry

Rochester, NY USA
1985

Doctorate - University of Rochester

Ph.D.
Rochester, NY USA
1983

Undergraduate - Clarkson University

Chemistry
Potsdam, NY USA
1978

• Dermatology

• American Academy of Dermatology
• Society of Investigative Dermatology
• American Association of Cancer Research

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/4/2008, Dr. Maytin has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

• English